Literature DB >> 11733539

High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal.

Takafumi Wataya1, Akihiko Nunomura, Mark A Smith, Sandra L Siedlak, Peggy L R Harris, Shun Shimohama, Luke I Szweda, Matthew A Kaminski, Jesus Avila, Donald L Price, Don W Cleveland, Lawrence M Sayre, George Perry.   

Abstract

Protein adducts of the lipid peroxidation product trans-4-hydroxy-2-nonenal (HNE) are features of oxidative damage in neuronal cell bodies in Alzheimer's disease but are also seen in axons of normal as well as diseased individuals. In this study, focusing on the axons of the mouse sciatic nerve, we found that HNE adducts characterize axons of mice from birth to senility. Immunoblots of axonal proteins showed that HNE adducts are only detected in neurofilament heavy subunit (NFH) and, to a lesser extent, neurofilament medium subunit (NFM), both lysine-rich proteins, consistent with the adducts being limited to lysine residues. In vitro, HNE treatment of permeabilized sciatic nerve showed the same specificity, i.e. NFH and NFM are the only proteins that reacted with HNE, providing they are phosphorylated. Quantitative immunoblot analysis of two strains of mice ages 1-33 months showed that the levels of HNE adducts on NFH are consistent throughout life. Additionally, mice transgenic for human superoxide dismutase-1 with G85R mutation show no difference in HNE adduction to NFH compared with controls. Taken together, these studies indicate that HNE adduction to NFH is physiological, and its constancy from birth to senility as well as its dependence on phosphorylation argues that NFH and NFM modification may play a role in protecting the membrane-rich axon from toxic aldehydes resulting from oxidative damage.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733539     DOI: 10.1074/jbc.M110913200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein.

Authors:  Lawrence J Marnett; James N Riggins; James D West
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 2.  A novel perspective on tau in Alzheimer's disease.

Authors:  D J Bonda; R J Castellani; X Zhu; A Nunomura; H-g Lee; G Perry; M A Smith
Journal:  Curr Alzheimer Res       Date:  2011-09       Impact factor: 3.498

3.  Early involvement of lysosome dysfunction in the degeneration of cerebral cortical neurons caused by the lipid peroxidation product 4-hydroxynonenal.

Authors:  Shi Zhang; Erez Eitan; Mark P Mattson
Journal:  J Neurochem       Date:  2017-02-16       Impact factor: 5.372

Review 4.  The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications.

Authors:  George Perry; Lawrence M Sayre; Craig S Atwood; Rudolph J Castellani; Adam D Cash; Catherine A Rottkamp; Mark A Smith
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 5.  Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders.

Authors:  Mark P Mattson; Dong Liu
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

6.  High-throughput proteomic-based identification of oxidatively induced protein carbonylation in mouse brain.

Authors:  Brian A Soreghan; Frank Yang; Stefani N Thomas; Jennifer Hsu; Austin J Yang
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

Review 7.  Oxidative stress in diabetes and Alzheimer's disease.

Authors:  V Prakash Reddy; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 8.  The mechanisms of Mallory-Denk body formation are similar to the formation of aggresomes in Alzheimer's disease and other neurodegenerative disorders.

Authors:  S W French; A S Mendoza; Y Peng
Journal:  Exp Mol Pathol       Date:  2016-04-09       Impact factor: 3.362

9.  Lipid peroxidation up-regulates BACE1 expression in vivo: a possible early event of amyloidogenesis in Alzheimer's disease.

Authors:  Liuji Chen; Ren Na; Mingjun Gu; Arlan Richardson; Qitao Ran
Journal:  J Neurochem       Date:  2008-08-02       Impact factor: 5.372

Review 10.  Phosphorylated tau: toxic, protective, or none of the above.

Authors:  Rudy J Castellani; Akihiko Nunomura; Hyoung-gon Lee; George Perry; Mark A Smith
Journal:  J Alzheimers Dis       Date:  2008-08       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.